C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2009
12/16/2009	EP2132185A2 Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands
12/16/2009	EP2132177A1 Pim kinase inhibitors and methods of their use
12/16/2009	EP1778684B1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR
12/16/2009	CN101605766A Pyrimidines derivatives and their use as kinase inhibitors
12/16/2009	CN101605765A Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures
12/16/2009	CN101602757A 4-substituent-2-amido pyrimidine compound and preparation method thereof
12/16/2009	CN101602734A Method for preparing Erlotinib hydrochloride crystal form A
12/16/2009	CN101602733A Diaryl pyridine derivatives, preparation method thereof and application thereof
12/16/2009	CN101602732A Derivative of acyl thiourea pyridine, method for preparing same and application thereof
12/16/2009	CN100569769C Compounds with antibacterial activity
12/15/2009	US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009	US7632840 Quinazoline compounds for the treatment of hyperproliferative disorders
12/15/2009	CA2529611C Pyrimidine derivatives for the treatment of abnormal cell growth
12/15/2009	CA2481078C Method and compositions for the synthesis of bch-189 and related compounds
12/15/2009	CA2424580C C-nitrosoaniline compounds and their blends as polymerization inhibitors
12/15/2009	CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
12/10/2009	WO2009147843A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
12/10/2009	WO2009147418A1 Substituted quinazolines
12/10/2009	WO2009147079A1 3,4-dihydropyrimidine trpa1 antagonists
12/10/2009	WO2009146648A1 Amide compounds, preparation methods and uses thereof
12/10/2009	WO2009127642A3 Use of lrrk2 inhibitors for neurodegenerative diseases
12/10/2009	WO2009081112A3 Chemical compounds
12/10/2009	WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009	US20090306380 Process for preparing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde
12/10/2009	US20090306379 POLYMORPHS OF BENZOATE SALT OF 2-[[6-[(3r)-3-AMINO-1- PIPERIDINYL]-3,4-DIHYDRO-3- METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL]METHYL]-BENZONITRILE AND METHODS OF USE THEREFORE
12/10/2009	US20090306378 Process for preparing aminocrotonylamino-substituted quinazoline derivatives
12/10/2009	US20090306377 Novel process for the prepartion of erlotinib
12/10/2009	US20090306375 Process for production of 4(3H)-quinazolinone derivative
12/10/2009	US20090306117 Rosuvastatin zinc salt
12/10/2009	US20090306116 Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity
12/10/2009	US20090306115 Phenyl ethyne compounds
12/10/2009	US20090306114 Polymorphic and Other Crystalline Forms of Cis-FTC
12/10/2009	US20090306112 Antiviral protease inhibitors
12/10/2009	US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009	US20090306109 Fungicide active substance combinations
12/10/2009	US20090306108 Substituted pyrimidinones
12/10/2009	US20090306105 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
12/10/2009	US20090306072 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
12/10/2009	US20090306044 Quinazoline derivatives for the treatment of cancer diseases
12/10/2009	US20090306022 7-substituted tetracycline compounds
12/10/2009	US20090305894 use of sulfonanilides as herbicide
12/10/2009	CA2726579A1 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
12/10/2009	CA2724878A1 3,4-dihydropyrimidine trpa1 antagonists
12/10/2009	CA2724376A1 Substituted quinazolines
12/09/2009	EP2130823A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
12/09/2009	EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009	EP2129665A1 Quinazolinone derivatives as aldh-2 inhibitors
12/09/2009	EP2129664A1 Trisubstituted triazamacrocycli c compounds and their use as contrast agents
12/09/2009	EP2129653A2 Novel p2y12 receptor antagonists
12/09/2009	EP2129222A1 Diaminopyrimidines as fungicides
12/09/2009	EP2129221A2 Polymorphs of 3-(e)-2-{2-[6-(2-cyanophenoxy) pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
12/09/2009	EP1692140B1 Compositions useful as inhibitors of protein kinases
12/09/2009	EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	EP1175407B1 Pesticidal pyrimidine-derivatives
12/09/2009	CN101600698A Quinazolinone and isoquinolinone acetamide derivatives
12/09/2009	CN101600697A New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
12/09/2009	CN101597265A Method for synthesizing bromacil technical
12/09/2009	CN101597264A Method for synthesizing cytimidine
12/09/2009	CN101597263A Preparation method and use of novel S-DABO HIV-1 reverse transcriptase inhibitor
12/09/2009	CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009	CN100567279C Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors
12/09/2009	CN100567266C Cannabinoid receptor ligands
12/08/2009	US7629462 Such as (5-Aminomethyl-2-methylsulfanyl-6-phenyl-pyrimidin-4-yl)-phenylamine; p38 map kinase inhibitors
12/08/2009	US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009	US7629348 Insecticides; for human or veterinary medicine
12/08/2009	US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
12/08/2009	US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009	CA2415486C Pyramidine derivatives
12/08/2009	CA2411155C Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
12/08/2009	CA2314613C Azolo triazines and pyrimidines
12/03/2009	WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009	WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009	WO2009144584A1 Anti-ligands molecules and biological applications
12/03/2009	WO2009143945A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
12/03/2009	WO2009143776A1 Preparation method of rosuvastatin calcium and its intermediates
12/03/2009	WO2009108657A3 Heteroaryl derivatives as cftr modulators
12/03/2009	WO2009096667A4 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
12/03/2009	US20090299065 Process for the manufacture of organic compounds
12/03/2009	US20090298823 Inhibitors of protein kinases
12/03/2009	CA2726009A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumours
12/03/2009	CA2725220A1 Ant-ligands molecules and biological applications
12/03/2009	CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009	CA2725052A1 Preparation method of rosuvastatin calcium and its intermediates
12/03/2009	CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/02/2009	EP2128141A1 Process for producing trichloropyrimidine compound
12/02/2009	EP2125754A1 An improved process for preparation of rosuvastatin calcium
12/02/2009	EP2124560A1 2-aminopyrimidine modulators of the histamine h4 receptor
12/02/2009	EP1965805B1 Urea derivatives useful as calcium receptor modulators
12/02/2009	EP1581477B1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/02/2009	EP1503763B1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
12/02/2009	EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009	CN101594870A 4-aminoquinazoline derivatives and methods of use thereof
12/02/2009	CN101591302A Preparation technique of heptenoic acid ester derivative
12/02/2009	CN101591301A Preparation method of 3, 5-dihydroxy heptyl-6-gadoleic acid derivative
12/02/2009	CN100564366C Derivatives of 1,3-diones having a herbicidal activity
12/02/2009	CN100564362C Method for preparing azoxystrobin and its analogue
12/01/2009	US7626019 Antiproliferative agents
12/01/2009	US7625922 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds

1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 427